137 related articles for article (PubMed ID: 3034662)
1. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas.
Faure GC; Bene MC; Bolle-Chanal MH
Eur J Haematol; 1987 Jan; 38(1):26-30. PubMed ID: 3034662
[TBL] [Abstract][Full Text] [Related]
2. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
3. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
4. The expression of the p75 subunit of interleukin 2 receptor in Tac negative leukemic cells of two patients with large granular lymphocytic leukemia.
Tagawa S; Hatakeyama M; Shibano M; Taniguchi T; Kitani T
Blood; 1988 Apr; 71(4):1161-4. PubMed ID: 2833327
[TBL] [Abstract][Full Text] [Related]
5. Expression of Tac antigen by non-Hodgkin's lymphomas.
Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
[TBL] [Abstract][Full Text] [Related]
6. Expression of Tac antigen on human immature B-cell lineage leukemic cells.
Matsuoka M; Hattori T; Kawano F; Ishii T; Uchiyama T; Takatsuki K
Leuk Res; 1986; 10(6):597-603. PubMed ID: 3086629
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin-2 receptor on T cell chronic lymphocytic leukemia cells and their response to interleukin-2.
Tsudo M; Uchiyama T; Umadome H; Wano Y; Hori T; Tamori S; Uchino H; Kita K; Chiba S; Mitsutani S
Blood; 1986 Feb; 67(2):316-21. PubMed ID: 3080037
[TBL] [Abstract][Full Text] [Related]
8. Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens.
Schroff RW; Foon KA; Billing RJ; Fahey JL
Blood; 1982 Feb; 59(2):207-15. PubMed ID: 7034809
[TBL] [Abstract][Full Text] [Related]
9. Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal.
Perri RT; Kay NE
Leukemia; 1987 Feb; 1(2):127-30. PubMed ID: 3118104
[TBL] [Abstract][Full Text] [Related]
10. Expression of Tac antigen in B cell lymphomas.
Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
[TBL] [Abstract][Full Text] [Related]
11. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population.
Foa R; Giovarelli M; Jemma C; Fierro MT; Lusso P; Ferrando ML; Lauria F; Forni G
Blood; 1985 Sep; 66(3):614-9. PubMed ID: 2992637
[TBL] [Abstract][Full Text] [Related]
13. Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation.
Touw I; Delwel R; Bolhuis R; van Zanen G; Löwenberg B
Blood; 1985 Sep; 66(3):556-61. PubMed ID: 3161562
[TBL] [Abstract][Full Text] [Related]
14. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
[TBL] [Abstract][Full Text] [Related]
15. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
17. T-cell colony formation in patients with T-cell malignancies: growth factor requirements for in-vitro proliferation of peripheral blood T-cell colony-forming cells.
Georgoulias V; Triebel F; Kosmatopoulos C; Allouche M; Gluckman JC; Mathe G; Jasmin C
Leuk Res; 1986; 10(4):419-27. PubMed ID: 3007873
[TBL] [Abstract][Full Text] [Related]
18. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
Said JW; Pinkus GS
Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.
Muraguchi A; Kehrl JH; Longo DL; Volkman DJ; Smith KA; Fauci AS
J Exp Med; 1985 Jan; 161(1):181-97. PubMed ID: 2981952
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.
Dillman RO; Beauregard JC; Lea JW; Green MR; Sobol RE; Royston I
J Clin Oncol; 1983 Mar; 1(3):190-7. PubMed ID: 6607975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
